During the 19th Annual Meeting ov the Japanese Vaccine Society Michiho OHARA announced having developed a recombinant vaccinia virus vaccine (LC16m8rVV-Flu HA) effective against H5N1 influenza.
Nikkei Biotech news release, November 18, 2015
Team at Tokyo Metropolitan Medical Research Institute develops recombinant vaccine against H5N1 flu